Choline
Also called: choline bitartrate, phosphatidylcholine, lecithin
An essential nutrient found in some foods and sold as a supplement. It supplies methyl groups and is needed to make the membrane phospholipids phosphatidylcholine and sphingomyelin and the neurotransmitter acetylcholine.
- Category
- Other
- Forms
- Choline bitartrate, phosphatidylcholine and lecithin
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2003 Cochrane review identified 12 randomized placebo-controlled trials of lecithin (a phosphatidylcholine source) in people with Alzheimer's disease (265), Parkinsonian dementia (21) or subjective memory problems (90); few contributed to meta-analyses. The count covers lecithin, not choline bitartrate. [3]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CBrain, mood and sleep2 topics
CHeart and blood vessels1 topic
CLiver1 topic
CPregnancy and infants1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Cognitive function in healthy adults | C | Observational studies linked higher choline status or intake to better cognition, but a 2015 systematic review of 13 studies found no clear cognitive improvement from choline in healthy adults. [1] |
| Dementia (lecithin) | C | A 2003 Cochrane review of 12 trials found no clear clinical benefit of lecithin for Alzheimer's disease or Parkinsonian dementia. [1] |
| Cardiovascular disease | C | Large observational studies found no significant link between choline intake and cardiovascular or peripheral artery disease; one analysis of about 120,000 people linked higher intake to higher mortality. [1] |
| Neural tube defects | C | Some evidence links lower maternal blood choline to higher neural tube defect risk; other research found no such relationship. [1] |
| Nonalcoholic fatty liver disease | C | Observational and small studies link low choline intake to liver dysfunction or fibrosis; ODS states further research is needed. [1] |
Main constituents: Choline (as choline bitartrate, phosphatidylcholine or lecithin) [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Supplements typically contain 10 mg to 250 mg choline. Prenatal supplements typically contain little if any choline. [1]
- Adequate Intake, adults 19 and older: 550 mg/day for men and 425 mg/day for women; 450 mg/day in pregnancy and 550 mg/day in lactation. [1]
Upper limits
- UL for adults 19 and older (including pregnancy and lactation): 3,500 mg/day, based on amounts associated with low blood pressure (hypotension) and fishy body odor. [1]
Safety and side effects
- Liver (NIH LiverTox)See details
NIH ODS: high intakes of choline are associated with a fishy body odor, vomiting, excessive sweating and salivation, hypotension and liver toxicity.
Details and sources - Pregnancy and breastfeedingNIH ODS: approximately 90%–95% of pregnant women consume less choline than the Adequate Intake (450 mg/day in pregnancy …
1 statement in the profile.
Details and sources - Interactions with medicinesNone reported
Medications (general): NIH ODS: choline is not known to have any clinically relevant interactions with medications.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications8 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Very high intakes are associated with fishy body odor, vomiting, excessive sweating and salivation, hypotension and liver toxicity. [1]
Interactions
| With | What happens |
|---|---|
| Medications | Choline is not known to have any clinically relevant interactions with medications. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- No studies have compared the bioavailability of the different supplemental forms of choline. [1]
Regulatory status
- US: available as a dietary supplement alone, combined with B-complex vitamins, and in some multivitamin/mineral products. [1]
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [2]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 8 entries naming choline or a choline compound (for example choline alfoscerate, alpha-glyceryl phosphoryl choline, lysophosphatidylcholine) (earliest NDI 69 submitted 1999-09-20; most recent NDI 1360 submitted 2024-09-12). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of choline was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
Liver (NIH LiverTox)
- NIH ODS: high intakes of choline are associated with a fishy body odor, vomiting, excessive sweating and salivation, hypotension and liver toxicity. No LiverTox chapter on choline was found. [P5]
Interactions with medicines
- Medications (general): NIH ODS: choline is not known to have any clinically relevant interactions with medications. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition for an exemption under 111.75(a)(1)(ii). [P2]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- NIH ODS: free choline, phosphocholine and glycerophosphocholine are absorbed in the small intestine; phosphatidylcholine and sphingomyelin are absorbed intact. Precise estimates of the percentage absorption of the different forms in humans are not available, and no studies have compared their relative bioavailability. [P5]
- NIH ODS: intestinal bacteria convert some choline to trimethylamine (TMA), which the liver converts to TMAO; choline intake increases TMAO production in a dose-dependent manner in adults. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- NIH ODS: approximately 90%–95% of pregnant women consume less choline than the Adequate Intake (450 mg/day in pregnancy; 550 mg/day in lactation), and prenatal dietary supplements typically contain little if any choline. The UL in pregnancy and lactation is 3,500 mg/day for ages 19 and older. [P5]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- PubChem. Choline, CID 305 (description from ChEBI; retrieved via PUG-REST 2026-10-29), 2026-10-29. pubchem.ncbi.nlm.nih.gov
- NIH Office of Dietary Supplements. Choline: Fact Sheet for Health Professionals (updated June 2, 2022), 2022-06-02. ods.od.nih.gov
Sources
- NIH Office of Dietary Supplements. Choline: Fact Sheet for Health Professionals (Updated: June 2, 2022), 2022-06-02. ods.od.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- Higgins JP, Flicker L. Lecithin for dementia and cognitive impairment. Cochrane Database Syst Rev 2003(3):CD001015 (PMID 12917896), 2003. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.